Skip to main content
. Author manuscript; available in PMC: 2017 May 23.
Published in final edited form as: Receptors Clin Investig. 2016 May 23;3(2):e1310.

Figure 8. A proposed mechanism for the role of MVP in Beclin-1/Vps34/MYH9 complex-mediated cell death.

Figure 8

The ROS-dependent S-glutathionylation of MVP triggers the binding of the MYH9 complex along with vascular protein sorting 34 (Vps34) and Beclin-1 to the vault complex, inhibiting Beclin-1-dependent cell death. Glutaredoxin 1 (Grx1) and thioredoxin (Trx), which inhibit this cell survival mechanism, enhance smooth muscle cell death.